What is barberry
Barberry also known as berberis is a large genus of deciduous and evergreen shrubs from 1–5 m (3.3–16.4 ft) tall found throughout the temperate and subtropical regions of of Asia, Europe, Africa, North America, and South America. The genus Berberis (Berberidaceae) includes about 500 species that commonly occur in most areas of central and southern Europe, the northeastern region of the United States and in South Asia including the northern area of Pakistan and Iran 1, 2. Many of the species have spines on the shoots and along the margins of the leaves 3. Among the several species of this genus, Berberis vulgaris (barberry) is well known and its fruits have been used in the preparation of a special dish with rice and also in Berberis juice 4, 5, 6. The fruits of most plants from Berberidaceae family have a sour taste which is due mainly to the presence of ascorbic acid or vitamin C.
In traditional medicine, different organs of this plant are used to treat diseases. Fruit, bark, root, and stem are the pharmaceutical organs of Berberis vulgaris. Barberry fruit is the most frequently used organ of this plant in traditional and modern medicine 7. Sometimes Berberis vulgaris has been used as a tea made from the bark of the plant 8. Besides nutritional consumption, various parts of this plant including roots, bark, leaves and fruits have been employed in folk and traditional medicine for a long time in Iran 8, 9. The stem and root barks are used for their cathartic (laxative effect), diuretic (increased passing of urine), antipyretic (reduce fever), anti-bilious (anti nausea or vomiting), and antiseptic properties. Also, the decoction of leaves is used as anti-scorbutic (preventing or curing scurvy) in dysentery, scurvy angina, and sore throat 10.
In Iran, dried barberry fruit is used in many foods — the fruit or its derivatives are used to produce certain products such as sauce, jelly, juice, jam, marmalade, and carbonated drinks. Besides that, barberry is used to season, flavor, and garnish foods to satisfy different flavors 11. This fruit is also used in industries. For example, the anthocyanin found in barberry fruit is used as a nature-based color 12.
Iran is the biggest producer of Berberis vulgaris (barberry) fruit in the world, with 11,000 hectares of land under cultivation. Over 10,000 tons of dried barberry fruit are produced in Iran per year. Among the provinces of Iran, Southern Khorasan is one of the biggest producers of Berberis vulgaris. Over 97% of all the lands under Berberis vulgaris cultivation are located in Ghaenat County, Southern Khorasan province, producing 95% of the whole Berberis vulgaris fruit in Iran 13.
Different organs of Berberis vulgaris are used in food and pharmaceutical industries and the decorative species are used to decorate different places. According to traditional medicine, Berberis vulgaris is used to treat fever, cough, liver disease, depression, hyperlipidemia, hyperglycemia and bleeding 14, 15.
Figure 1. Barberry fruit
Various species of the genus Berberis which occur around the world are cultivated and grown for specific purposes 16. Berberis vulgaris is the most widely known barberry which is mainly used as a food is cooked with rice (seedless or red), Berberis integerrima, also referred to as black barberry and wild barberry, are used mainly for juice extraction in food industries and as medication 17, 18.
Nutrition facts of barberry (Berberis vulgaris fruit)
Berberis vulgaris fruit is sour and contains different nutrients including dextrose, fructose, malic acid, tartaric acid, citric acid, pectin, and resin. It is also rich in vitamins C and A, calcium, iron, and potassium 19, 20. In Berberis vulgaris fruit, the concentrations of iron, zinc, copper, and manganese are estimated 2,650 mg/kg, 27.5 mg/kg, 33.7 mg/kg, and 58.6 mg/kg, respectively 18. Decomposition of Berberis vulgaris fruit shows that this fruit contains 79.6% humidity, 1.16% fat, 2% protein, 16.24% carbohydrate, and 0.99% ash. The amount of anthocyanin is estimated 281 mg/l 21.
Medicinal uses of barberry (Berberis vulgaris) in Chinese medicine date back to over 3000 years ago and in some other countries to over 2500 years ago 9. There are a variety of alkaloids in the various organs of this plant, most important of which is berberine 22. Berberine, an isoquinoline alkaloid, is a member of naturally occurring protoberberines class (Figure 2), can exert different effects, including antioxidant, anti-inflammatory, hypoglycemic, hypotensive, and hypolipidemic activities 23, 24..
Figure 2. Chemical structure of Berberine and its metabolites
This alkaloid is present in plants of Berberidaceae, Papaveraceae and Ranunculaceae families including Arcangelisia flava (menispermaceae), B. vulgaris (barberry), B. aristata (tree turmeric), B. aquifolium (Oregon prape), B. lyceum, B. crataegina, Hydrastis canadensis (goldenseal) and Coptis chinensis (Chinese goldthread). Berberine widely consumed in Ayurvedic and Chinese medicine 26, 27, 28. Berberine has been isolated from various parts of these species such as root, stem, bark, fruit and rhizome 27.
Traditional use of root, bark, leaf and fruits of barberry as an immunemodulator and anti-microbial agent as well as a treatment for central nervous system, cardiovascular, gastrointestinal, endocrine, and renal problems have been shown in two pharmacological studies 26, 29. Recently published articles using animal subjects and laboratory test tubes test have demonstrated that barberry and berberine (its main constituents) have anti-oxidant 14, anti-inflammatory 30, anti-tumor 31, anti-mutagenic 32 and anti-diabetic 14 effects. Their hypoglycemic and cholesterol lowering properties 33, neuroprotective 34, and hepatoprotective 35, effects have scientifically been proved by numerous studies. B. vulgaris may possesses preventive effects in relapse of morphine consumption in addicted individuals 36. It has been demonstrated that B. vulgaris and berberine induces inhibitory effects on Leishmania species 37. Also, it has been reported as an anti-fungal compound 38. There are evidences in vivo and in vitro that berberine hydrochloride has beneficial effects on colitis 39.
- Berberis vulgaris (barberry),
- Berberis orthobotrys,
- Berberis khorasanica,
- Berberis integerrima, Berberis crataegina, Berberis lycium, and Berberis aristata are used in traditional medicine more frequently in Iran and other parts of the world.
Table 1. Pharmacological and biological activity of the various species of Berberis genus
Many metabolites of various species of Berberis vulgaris have been reported, but the main isolated compounds from Berberis vulgaris are tannins, vitamin C, carotenoid, phenolic compounds, triterpenes (lupeol, oleanolic acid), sterols (stigmasterol, stigmasterol glucoside), alkaloids (berberamine, palmatine, berberine, oxyberberine, columbamine, isocorydine, lambertinea and magniflo-rine), anthocyanin and phenolic compounds 42. Besides, bisbenzlisoquinolines (oxycanthine), N-(p-trans- coumaroyl) tyramine, cannabisin G and (±)-lyoniresinol have been isolated from this plant 23.
Table 2. The main isolated compounds reported from different species of Berberis
Most compounds are summarized in Table 2. The highest amounts of phenolic compounds and anthocyanins can be found in Berberis vulgaris juice and the highest amount of flavonoid compounds in B. vulgaris leaves. Regarding the importance of investigating B. vulgaris quality, the amount of anthocyanin in the fruit to be an important index of B. vulgaris quality 44. The concentrations of flavonol, flavonoid, and phenol of B. vulgaris fruit are 25.3 mg/g, 12.2 mg/g, and 0.54 mg/g, respectively 18.
In all parts of B. vulgaris plant, certain alkaloids such as berberine, oxyaconthine, berbamine, brolicin, and columbamine are found. The amount of alkaloid is higher in the root bark than other organs of B. vulgaris. Berberine is one of the most important alkaloids of this plant that can be effective in preventing coronary artery disease and possibly reducing the levels of total cholesterol and triglyceride 45. The most important property of berbamine is to block calcium channels. This alkaloid was found to be active in the tests of lipids peroxidation in red blood cells and can exert anti-myocardial ischemia and antiarrhythmic effects. Besides that, oxyaconthine has a sympatholytic and vasodilatory agent 46.
Table 3. Summary of active metabolites in Barberry
|Disease||Type of study||Berberis species||Part of plant||Results||References|
|Cancer||Experimental (mice)||Berberis aristata||Fruit||Ethanolic extract was observed to be efficient and the presence of alkaloids and flavonoids may be responsible for the observed anticancer effects.||47|
|Human colon cancer cell line||B. aristata||Stem||Methanolic extract induces a concentration- dependent inhibition of HT29 cells, with an IC50 of 1.8964 μg/ml after 72 hours of incubation.||48|
|Experimental ( rat)||Berberis vulgaris||Fruit||The fruit can reduce the activity of liver enzymes and inhibit the gene expression of alpha-fetoprotein in rats during hepatocarcinogenesis.||49|
|Human prostate cancer cell lines||Berberis libanotica||Root||Ammonia-dichloromethane extract showed a high therapeutic potential to target prostate cancer and its cancer stem cells.||50|
|P53-deficient HL- 60 cells||Berberis lycium||Root||Berberine and the butanolic extract inhibited the expression of the proto-oncogene cyclin D1 and induced the acetylation of α-tubulin. This correlated with the induction of apoptosis. The data demonstrate that berberine is a potent anti-neoplastic compound that acts via anti-proliferative and pro-apoptotic mechanisms independent of genotoxicity.||51|
|Experimental (Rat)||Berberis vulgaris||Fruit||Microscopic examinations of the TUNEL- positive apoptotic cells demonstrated a significant difference between cancer control and normal control group. Increasing concentration of B. vulgaris aqueous extract in cancerous treated groups showed considerable increase in TUNEL-positive cells compared with the cancer control group, and apoptotic cells increased with increase in B. vulgaris extract concentration in cancerous groups.||52|
|Antihistaminic||Experimental (guinea-pig ileum) Experimental (male Sprague- Dawley rats)||Berberis vulgaris||Fruit||The results indicated antihistaminic and anticholinergic activities of the extract, potentially competitive.||53|
|Experimental (male Sprague-Dawley rats)||Berberis vulgaris||Fruit||Aqueous extract has beneficial effects on both cardiovascular and neural systems, suggesting a potential use to treat hypertension, tachycardia, and some neurological disorders, such as epilepsy and convulsion.||54|
|Cardiovascular / Hypertension||Experimental ( rat)||Berberis orthobotrys||Root||It causes decrease in systolic blood pressure||55|
|Experimental ( rat)||Berberis integerrima||fruit||B. integerrima reduced systolic blood pressure in the right ventricle.||56|
|Experimental (rat)||B. vulgaris||Fruit||Aqueous extract has beneficial effects on both cardiovascular and neural systems, suggesting a potential use to treat hypertension, tachycardia, and some neurological disorders, such as epilepsy and convulsion.||54|
|Experimental (mice and rat)||Berberis crataegina||Root||The anti-inflammatory activity of the extracts and fractions, inhibited oil-induced diarrhea. The active constituent, berberine also showed a dose-dependent and potent analgesic activity against acetic acid-induced writhing reflex in mice||57|
|Gastrointestinal||In vitro and in vivo||B. aristata||Bark||The onset of castor oil-induced diarrhea was delayed and the number of diarrheal episodes was reduced by the extract in a dose- dependent manner.||58|
|Experimental (Swiss albino mice)||B. aristata||Stem||B. aristata produces antidiarrheal effect through decreasing intestinal secretions and antispasmodic effect through inhibiting intestinal motility.||59|
|Experimental (mice)||Berberis integerrima L.||Root||B. integerrima has anticonvulsant activity in pentylenetetrazol-induced seizures.||60|
|Epilepsy||Experimental (mice)||B. vulgaris||isoquinoline alkaloid of berberine.||Berberine exhibits anticonvulsant activity by modulating neurotransmitter systems and may have clinical uses.||61|
|Fever / Antibacterial||laboratory experimental||B. aristata||Root and Stem||B. aristata root extract gave low MICs values against Bacillus cereus, Escherichia coli, Staphylococcus aureus, and Aspergillusflavus while stem extract against B. cereus and Streptococcus pneumoniae.||62|
|laboratory experimental||B. vulgaris||Bark of barberry root||The root bark exhibited anti-parasitic and antiseptic effects and is prescribed to lower fever.||63|
|Experimental (rat)||B. vulgaris||Root||The amount of cholesterol, triglyceride, and LDL decreased significantly.||64|
|Experimental (white rabbits)||B. aristata||–||B. aristata caused a significant reduction in serum cholesterol, triglycerides, and LDL levels; moreover, there was an increase in thrombin and fibrinogen time.||65|
|Experimental (rat)||B. aristata DC||Stem||Significant hypoglycemic activity and hypolipidemic activity was exhibited by the methanolic extract.||66|
|Lipid profile||Experimental (rat)||B. orthobotrys||Rroot||The crude extract significantly prevented the increase in LDL, VLDL, total cholesterol, triglyceride, atherogenic index, and coronary risk index in high fat diet, cholesterol, fructose and olive oil-induced hyperlipidemic rat model.||67|
|Experimental (rabbit)||B. lycium||Root||B. lycium treatment increased the levels of high density lipids.||68|
|Experimental (rat)||B. lycium||Root||The extracts also lowered the levels of cholesterol, triglycerides, LDL, VLDL, serum glutamic oxaloacetic transaminase, serum glutamic-pyruvic transaminase, and serum ALP in diabetic rats.||69|
|Diabetes||Experimental (rat)||B. vulgaris||Bark of barberry root||Blood glucose levels of the diabetic rats treated with aqueous extract decreased on the first day. This condition remained roughly constant for three weeks. Both extracts also declined biochemical parameters significantly.||70|
|Experimental (rat)||B. aristata||Root||The extract has strong potential to regulate glucose homeostasis through decreased gluconeogenesis and oxidative stress.||71|
|Experimental (rat)||B. lyceum||Root||Oral administration of 50 mg/kg of the extract and berberine to normal and experimental diabetic rats caused a significant reduction in blood glucose levels from day 3 to day 7 of treatment. As well, significant effects were observed on the glucose tolerance, glycosylated hemoglobin, serum lipid profiles, and body weight of experimental animals.||72|
|Experimental (rat)||B. integerrima||Root||Aqueous extract improves renal dysfunction in streptozotocin-induced diabetes in rats through controlling blood glucose and renal protective effects.||73|
|Experimental (rat)||B. integerrima||Root||Aqueous extract has hypoglycemic, hypolipidemic, and antioxidant effects in streptozocin-induced diabetes in rats.||74|
|Experimental (rat)||B. integerrima||Root||Aqueous extract had a desirable effect on the testosterone level, blood glucose, and histological changes of testes during the course of diabetes.||75|
Recently, berberine has been reported to decrease cholesterol through a mechanism different from that through which statins decrease cholesterol. If a statin and berberine are used simultaneously, they seem to control cholesterol more efficiently. In a controlled study, berberine was found to cause increase in a type of protein receptor in the liver, which could bond to cholesterol and facilitate its excretion 11. Despite extensive use and several properties of different organs of B. vulgaris, the action mechanisms of this plant remain to be clearly known. Some of these properties can be attributed to the antihistaminic and anticholinergic effects of this plant 77. There are large amounts of vitamin C in B. vulgaris fruit. Vitamin C is an antioxidant and water-soluble organic compound.
This vitamin is essential to the production and maintenance of collagen tissue and the strength of other tissues, and can help to reinforce immunity system and to speed up wound healing 78. As well, vitamin C prevents the formation of carcinogenic nitrosamines and nitrous ureas, and is considered a strong antioxidant agent and an effective cause of restoring cell enzymatic activities and electron transfer processes 47. It is also involved in the metabolism of carbohydrates, the conversion of folic acid to folinic acid, the metabolism of phenylalanine and thyrosine, the conversion of plasma transferine to liver ferritin, and the production of serotonin in the body 79.
A study on aqueous B. vulgaris fruit extract on antihistaminic and anticholinergic activities in guinea pig ileum confirmed that this extract could exert these effects 53.
Table 4. Summary of the findings on some species from genus Berberis most frequently used to treat different diseases
|Disease||Title of article||Berberis species||Part of plant||Results||References|
|Acne vulgaris||Aqueous extract of dried fruit of Berberis vulgaris L. in acne vulgaris, a clinical trial||Berberis vulgaris||Fruit||Oral aqueous extract of dried barberry is a safe, well-tolerated, and effective choice in teenagers with moderate to severe acne vulgaris.||80|
|Cardiovascular / Hypertention||The Effect of Berberis Vulgaris extract on blood pressure and weight of the patients suffered from Non-alcoholic fatty liver disease||B.vulgaris||Fruit||Mean systolic and diastolic blood pressure was significant compared to control group.||81|
|Cardiovascular / Hypertention||Effect of processed Berberis vulgaris in apple vinegar on blood pressure and inflammatory markers in type 2 diabetic patients.||B.vulgaris in apple vinegar||Fruit Of||findings had shown processed B.vulgaris had no effect on systolic- and diastolic blood pressure but apple vinegar had positive effect on interleukin-6. Nevertheless, further investigations about B.vulgaris effect on blood pressure and inflammatory markers are necessary.||82|
|Diabetes||Clinical trial ( patients with diabetes type 2)||Berberis||Fruit||The fruit had a significant reducing effect on serum glucose and decreased HbA1c levels during the 8 weeks of study.||83|
|Diabetes||Clinical trial (type 2 diabetic patients )||B.vulgaris||Fruit||Mean nutritional intake, anthropometric indices, hs CRP concentration, and systolic and diastolic blood pressure did not change in processed B. vulgaris. Also, interleukin-6 concentration did not change in processed B. vulgaris and control groups.||82|
|Diabetes||The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients||Berberis vulgaris||Fruit||The intake of 3 g/d B. vulgaris fruit extract for 3 months may have benefical effects on lipoproteins, apoproteins, glycemic control and total antioxidant capacity in type 2 diabetic patients.||84|
|Lipid profile||Clinical trial (dyslipidemic patients)||Berberis aristata||Fruit||B. aristata reduced total cholesterol, triglycerides, and LDL cholesterol and increased HDL cholesterol after three months.||85|
Many researchers reported pharmacological effects of B. vulgaris (Table 2 and 3). For example, Berberis aristata root extract caused decrease in glycemia and helped to regulate carbohydrate metabolism in diabetic rats 71. Moreover, the extract of Berberis vulgaris tree root is effective in treating and preventing the formation of stones in gastrointestinal tract 86. Berberis croatica Horvat is rich in berberine, phenol, and flavonol. The root extract of this plant can exert antimicrobial effects against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans 87. One of the main compounds of Berberis integerrima is berberine. Berberine can exert protective effects on central nervous system and help to treat the diseases of this system 60.
Moreover, this alkaloid can protect islets of Langerhans in diabetic mice and cause increase in insulin secretion, decrease in cholesterol and low-density lipoprotein, and increase in high-density lipoprotein 88. As with other fruits, B. vulgaris fruit contains salts and different vitamins including vitamin C. Ascorbic acid was found to exert positive effects on dementia progression in Alzheimer’s disease patients 89. In addition, the plasma levels of ascorbic acid were found to be lower in patients with dementia compared to the controls, representing the protective effect of ascorbic acid on the brain function and in preventing cognitive disorders 90. Moreover, ascorbic acid, a nature-based agent, has been reported to be effective in improving memory in patients and older animals 91.
These results briefly indicate that B. vulgaris contains a large number of phytochemical materials including ascorbic acid (vitamin C), vitamin K, several triterpenoids, more than 10 phenolic compounds and more than 30 alkaloids. Therefore B. vulgaris may have antihypertensive, anti-cancer, anti-inflammatory, antioxidant, antibacterial, analgesic and anti-nociceptive and hepato-protective effects 15, 92, 55.
Barberry side effects and toxicity
Results in animal and laboratory test tube studies have proved the potential of berberine (alkaloid derived from barberry) to induce gastrointestinal upset and ulceration, immunotoxicity, phototoxicity, neurotoxicity and cardiotoxicity in a dose dependent manner (Figure 3). Besides, there are controversial data in using berberine and its derivative during pregnancy, so the use of them should be cautioned in pregnancy and neonatal. Berberine by inhibiting adenine nucleotide translocase, promoting ROS (reactive oxygen species) formation, apoptosis and necrosis pathways induces its toxicity on both normal and cancer cell in a time and concentration dependent manner. In a biological context, ROS (reactive oxygen species) are formed as a natural byproduct of the normal metabolism of oxygen and have important roles in cell signaling and homeostasis. However, during times of environmental stress (e.g., UV or heat exposure), ROS levels can increase dramatically 93. This may result in significant damage to cell structures. Cumulatively, this is known as oxidative stress. Finally, the inhibitory effects of berberine on CYP enzymes should be mentioned which could evoke indirect toxicity. This interaction is important in co-administration with narrow therapeutic index drugs which may increase the drug plasma concentration and toxicity.
Nevertheless, as mentioned, these data mostly have been gathered from animal studies and there are differences between animals and human body, so more clinical studies in future could reveal the concealed toxicity of berberine and its derivatives.
Figure 3. Schematic diagram showing toxic effects of Berberis vulgaris and berberine in different animal toxicity tests
- Rounsaville TJ, Ranney TG. Ploidy levels and genome sizes of Berberis L. and Mahonia nutt. species, hybrids, and cultivars. Hortscience. 2010;45:1029–33.
- Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. Shamsa F, Ahmadiani A, Khosrokhavar R. J Ethnopharmacol. 1999 Feb; 64(2):161-6. https://www.ncbi.nlm.nih.gov/pubmed/10197751/
- Flora of China Vol. 19 Page 715 小檗属 xiao bo shu Berberis Linnaeus, Sp. Pl. 1: 330. 1753.
- Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol. 2005;102:46–52. https://www.ncbi.nlm.nih.gov/pubmed/15993555
- Shamsa F, Ahmadiani A, Khosrokhavar R. Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol. 1999;64:161–6. https://www.ncbi.nlm.nih.gov/pubmed/10197751
- Kosalec I, Gregurek B, Kremer D, Zovko M, Sankovic K, Karlovic K. Croatian barberry (Berberis croatica Horvat): A new source of berberine-analysis and antimicrobial activity. World J Microbiol Biotechnol. 2009;25:145–50.
- Madiseh MR, Heidarian E, Rafieian-kopaei M. Biochemical components of Berberis lycium fruit and its effects on lipid profile in diabetic rats. J Herb Med Pharmacol. 2014;3:1.
- Tomosaka H, Chin YW, Salim AA, Keller WJ, Chai H, Kinghorn AD. Antioxidant and cytoprotective compounds from Berberis vulgaris (Barberry) Phytother Res. 2008;22:979–81. https://www.ncbi.nlm.nih.gov/pubmed/18389483
- Fallah Huseini H, Zareei Mahmoudabady A, Mehrazma M, Alavian SM, Kianbakht S, Mehdizadeh M. The effects of taraxacum officinale L. and Berberis vulgaris L. root extracts on carbon tetrachloride induced liver toxicity in rats. J Med Plan. 2010;9:45–52.
- Saied S, Begum S. Phytochemical studies of Berberis vulgaris. Chem Nat Compd. 2004;40:137–40.
- Arayne MS, Sultana N, Bahadur SS. The berberis story:Berberis vulgaris in therapeutics. Pak J Pharm Sci. 2007;20:83–92. https://www.ncbi.nlm.nih.gov/pubmed/17337435
- Alemardan A, Asadi W, Rezaei M, Tabrizi L, Mohammadi S. Cultivation of Iranian seedless barberry (Berberis integerrima ’Bidaneh’):A medicinal shrub. Ind Crops Prod. 2013;50:276–287.
- Hesami M, Aliabaday S. Berberis use traditional Drtb National Seminar on Natural Products and Medicinal Plants, J North Khorasan Univ Med Sci 2012; Exclusive Magazine Conference. :31.
- Abd El-Wahab AE, Ghareeb DA, Sarhan EE, Abu-Serie MM, El Demellawy MA. In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complementary and Alternative Medicine. 2013;13:218. doi:10.1186/1472-6882-13-218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016550/
- Farhadi AK, Gavadifar K, Farha A. Effects of Berberise Vulgaris fruit extract on blood cholesterol and triglyceride in hyperlipidemic patients. Koomesh, J Semnan Univ Med Sci. 2008;9:211–216.
- Mozaffarian V. A Dictionary of Iranian Plant Names. Tehran-Iran: Farhang Moaser; 2007.
- Ardestani SB, Sahari MA, Barzegar M, Abbasi S. Some physicochemical properties of Iranian native barberry fruits (abi and poloei):Berberis integerrima and Berberis vulgaris. J Food Pharm Sci. 2013;1:3.
- Rahimi-Madiseh M, Gholami-Arjenaki M, Bahmani M, Mardani G, Farzan M, Rafieian-Kopaei M. Evaluation of minerals, phenolics and anti-radical activity of three species of Iranian berberis fruit . Derpharma Chemica. 2016;8:191–197.
- Rezaei M, Ebadi A, Reim S, Fatahi R, Balandary A, Farrokhi N, et al. Molecular analysis of Iranian seedless barberries via SSR. Sci Hortic. 2011;129:702–709.
- Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, et al. Effects of berberine on glucose metabolism in vitro. Metabolism. 2002;51:1439–1443. https://www.ncbi.nlm.nih.gov/pubmed/12404195
- Farhady Chitgar M, Varidy MJ, Varidy M. Evaluation of some physicochemical properties of Berberis crtagina. Bojnord-Iran: Book of the National Conference of natural products and herbs; 2012.
- Berberine. Altern Med Rev. 2000 Apr;5(2):175-7. http://www.altmedrev.com/publications/5/2/175.pdf
- Phytochemistry and pharmacology of berberis species. Mokhber-Dezfuli N, Saeidnia S, Gohari AR, Kurepaz-Mahmoodabadi M. Pharmacogn Rev. 2014 Jan; 8(15):8-15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931204/
- Bhardwaj D, Kaushik N. Phytochemical and pharmacological studies in genus Berberis. Phytochem Rev. 2012;11:523–542.
- Rad SZK, Rameshrad M, Hosseinzadeh H. Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. Iranian Journal of Basic Medical Sciences. 2017;20(5):516-529. doi:10.22038/IJBMS.2017.8676.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478780/
- Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:999–1012. https://www.ncbi.nlm.nih.gov/pubmed/18618524
- Singh IP, Mahajan S. Berberine and its derivatives:a patent review (2009-2012) Expert Opin Ther Pat. 2013;23:215–231. https://www.ncbi.nlm.nih.gov/pubmed/23231038
- Smolinske SC. Herbal product contamination and toxicity. J Pharm Pract. 2005;18:188–208.
- Imenshahidi M, Hosseinzadeh H. Berberis Vulgaris and berberine:an update review. Phytother Res. 2016;30:1745–1764. https://www.ncbi.nlm.nih.gov/pubmed/27528198
- Lin K, Liu S, Shen Y, Li Q. Berberine attenuates cigarette smoke-induced acute lung inflammation. Inflammation. 2013;36:1079–1086. https://www.ncbi.nlm.nih.gov/pubmed/23605560
- Yu FS, Yang JS, Lin HJ, Yu CS, Tan TW, Lin YT, et al. Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo. 2007;21:407–412. http://iv.iiarjournals.org/content/21/2/407.long
- Čerňáková M, Košt’álová D, Kettmann V, Plodová M, Tóth J, Dřímal J. Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium. BMC Complementary and Alternative Medicine. 2002;2:2. doi:10.1186/1472-6882-2-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC101396/
- Jiang Z, Liu F, Ong ES, Li SFY. Metabolic profile associated with glucose and cholesterol lowering effects of berberine in Sprague–Dawley rats. Metabolomics. 2012;8:1052–1068.
- Kulkarni SK, Dhir A. Berberine:a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 2010;24:317–324. https://www.ncbi.nlm.nih.gov/pubmed/19998323
- Hermenean A, Popescu C, Ardelean A, et al. Hepatoprotective Effects of Berberis vulgaris L. Extract/β Cyclodextrin on Carbon Tetrachloride–Induced Acute Toxicity in Mice. International Journal of Molecular Sciences. 2012;13(7):9014-9034. doi:10.3390/ijms13079014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430280/
- Imenshahidi M, Qaredashi R, Hashemzaei M, Hosseinzadeh H. Inhibitory Effect of Berberis vulgaris Aqueous Extract on Acquisition and Reinstatement Effects of Morphine in Conditioned Place Preferences (CPP) in Mice. Jundishapur Journal of Natural Pharmaceutical Products. 2014;9(3):e16145. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165176/
- Salehabadi A KM, Farzad MH, Namaei MH. Effect of root bark extract of Berberis vulgaris L. on leishmania major on BALB/c mice. Parasitol Res. 2014;113:953–957. https://www.ncbi.nlm.nih.gov/pubmed/24337510
- Mahmoudvand H, Ayatollahi Mousavi SA, Sepahvand A, et al. Antifungal, Antileishmanial, and Cytotoxicity Activities of Various Extracts of Berberis vulgaris (Berberidaceae) and Its Active Principle Berberine. ISRN Pharmacology. 2014;2014:602436. doi:10.1155/2014/602436. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964876/
- Minaiyan M, Ghannadi A, Mahzouni P, Jaffari-Shirazi E. Comparative Study of Berberis vulgaris Fruit Extract and Berberine Chloride Effects on Acetic Acid-Induced Colitis in Rats. Iranian Journal of Pharmaceutical Research : IJPR. 2011;10(1):97-104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869597/
- Singh M, Srivastava S, Rawat A. Antimicrobial activities of Indian Berberis species. Fitoterapia. 2007;78:574–576. https://www.ncbi.nlm.nih.gov/pubmed/17583443
- Roy S, Tyagi A, Shukla V, et al. Universal Plant DNA Barcode Loci May Not Work in Complex Groups: A Case Study with Indian Berberis Species. Joly S, ed. PLoS ONE. 2010;5(10):e13674. doi:10.1371/journal.pone.0013674. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965122/
- Rad SZK, Rameshrad M, Hosseinzadeh H. Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. Iranian Journal of Basic Medical Sciences. 2017;20(5):516-529. doi:10.22038/IJBMS.2017.8676. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478780/
- Mokhber-Dezfuli N, Saeidnia S, Gohari AR, Kurepaz-Mahmoodabadi M. Phytochemistry and Pharmacology of Berberis Species. Pharmacognosy Reviews. 2014;8(15):8-15. doi:10.4103/0973-7847.125517. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931204/
- Mazandarani M, Ghasemi N, Bayat H. The second review and comparison of active ingredients in plant organs of Berberis vulgaris L. J Plant Sci Res. 2013;8:59–17.
- Kong W, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344–1351. https://www.ncbi.nlm.nih.gov/pubmed/15531889
- Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res. 2005;19:222–225. https://www.ncbi.nlm.nih.gov/pubmed/15934023
- Pai K, Srilatha P, Suryakant K, Setty MM, Nayak PG, Rao CM, et al. Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice:A preliminary study. Pharm Biol. 2012;50:270–277. https://www.ncbi.nlm.nih.gov/pubmed/22085276
- Das S, Das MK, Mazumder PM, Das S, Basu SP. Cytotoxic activity of methanolic extract of Berberis aristata DC on colon cancer. Global J Pharmacol. 2009;3:137–140.
- Motalleb G, Hanachi P, Fauziah O, Asmah R. Effect of Berberis vulgaris fruit extract on alpha-fetoprotein gene expression and chemical carcinogen metabolizing enzymes activities in hepatocarcinogenesis rats. Iran J Cancer Prev. 2012;1:33–42.
- El-Merahbi R, Liu Y-N, Eid A, et al. Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells. Vinci MC, ed. PLoS ONE. 2014;9(11):e112453. doi:10.1371/journal.pone.0112453. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224486/
- Khan M, Giessrigl B, Vonach C, Madlener S, Prinz S, Herbaceck I, et al. Berberine and a Berberis lycium extract inactivate Cdc25A and induce α-tubulin acetylation that correlate with HL-60 cell cycle inhibition and apoptosis. MUTAT RES-FUND MOL M. 2010;683:123–130. https://www.ncbi.nlm.nih.gov/pubmed/19909759
- Hanachi P, Othman F, Motalleb G. Effect of Berberis vulgaris aqueous extract on the apoptosis, sodium and potassium in hepatocarcinogenic rats. Iran J Basic Med Sci. 2008;11:62–69.
- Shamsa F, Ahmadiani A, Khosrokhavar R. Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol. 1999;64:161–166. https://www.ncbi.nlm.nih.gov/pubmed/10197751
- Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi SA. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol. 2005;102:46–52. https://www.ncbi.nlm.nih.gov/pubmed/15993555
- Alamgeer A, Akhtar MS, Jabeen Q, Akram M, Khan HU, Karim S, et al. Antihypertensive activity of aqueous-methanol extract of Berberis orthobotrys Bien Ex Aitch in rats. Trop J Pharm Res. 2013;12:393–399.
- Mahdavi N, Joukar S, Najafipour H, Asadi-Shekaari M. The promising effect of barberry (Zereshk) extract against experimental pulmonary microvascular remodeling and hypertension:A comparison with sildenafil. Pharm Biol. 2015;54:1–7. https://www.ncbi.nlm.nih.gov/pubmed/26023989
- Yeşilada E, Küpeli E. Berberis crataegina DC. Root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. J Ethnopharmacol. 2002;79:237–248. https://www.ncbi.nlm.nih.gov/pubmed/11801387
- Joshi PV, Shirkhedkar AA, Prakash K, Maheshwari VL. Antidiarrheal activity, chemical and toxicity profile of Berberis aristata. Pharm Biol. 2011;49:94–100. https://www.ncbi.nlm.nih.gov/pubmed/20738174
- Shamkuwar P, Pawar D. Antidiarrhoeal and antispasmodic effect of Berberis aristata. Int J Pharm Phytochem Res. 2013;5:24–26.
- Hosseinzadeh H. Anticonvulsant effect of berberis integerrima L root extracts in mice. J Acupunct Meridian Stud. 2013;6:12–17. https://www.ncbi.nlm.nih.gov/pubmed/23433050
- Bhutada P, Mundhada Y, Bansod K, Dixit P, Umathe S, Mundhada D. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav. 2010;18:207–210. https://www.ncbi.nlm.nih.gov/pubmed/20638957
- Singh M, Srivastava S, Rawat R. Antimicrobial activities of Indian Berberis species. Fitoterapia. 2007;78:574–576. https://www.ncbi.nlm.nih.gov/pubmed/17583443
- Javadzadeh SM, Fallah SR. Therapeutic application of different parts berberis vulgaris. Int J Agri Crop Sci. 2012;4:404–408.
- Changizi Ashtiyani S, Zarei A, Taheri S, Rezaei A, Golshan M, Ghafarzadegan R. A Comparative Study of Hypolipidemic Activities of the Extracts of Melissa officinalis and Berberis vulgaris in Rats. J Med Plants. 2013;3:38–47.
- Razzaq FA, Khan RA, Feroz Z, Afroz S. Effect of Berberis aristata on lipid profile and coagulation parameters. African J Pharm Pharm. 2011;5:943–947.
- Upwar N, Patel R, Waseem N, Mahobia NK. Hypoglycemic effect of methanolic extract of Berberis aristata DC stem on normal and streptozotocin induced diabetic rats. Int J Pharm Pharm Sci. 2011;3:222–224.
- Ghuffar A, Ahmad T, Mushtaq MN. Antihyperlipidemic effect of Berberis orthobotrys in hyperlipidemic animal models. Bang J Pharmacol. 2014;9:377–382.
- Ahmed M, Alamgeer A, Sharif T, Zabta C, Akbar A. Effect of Berberis lycium Royle on lipid profile in alloxan induced diabetic rabbits. Ethnobotan Leaflets. 2009;13:702–708.
- Mustafaa KG, Ganai B, Akbar S, Dar M, Tantry M, Masood A. The extracts of Berberis lycium and diabetes mellitus in alloxan monohydrate induced diabetic rats. J Pharm Res. 2011;4:2570–2573.
- Meliani N, Dib MEA, Allali H, Tabti B. Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2011;1(6):468-471. doi:10.1016/S2221-1691(11)60102-0. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614224/
- Singh, Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol. 2009;123:22–26. https://www.ncbi.nlm.nih.gov/pubmed/19429334
- Gulfraz M, Mehmood S, Ahmad A, Fatima N, Praveen Z, Williamson E. Comparison of the antidiabetic activity of Berberis lyceum root extract and berberine in alloxan-induced diabetic rats. Phytother Res. 2008;22:1208–1212. https://www.ncbi.nlm.nih.gov/pubmed/18729256
- Ashraf H, Heidari R, Nejati V, Ilkhanipoor M. Aqueous extract of Berberis integerrima root improves renal dysfunction in streptozotocin induced diabetic rats. Avicenna Journal of Phytomedicine. 2013;3(1):82-90. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075691/
- Ashraf H, Heidari R, Nejati V, Ilkhanipoor M. Effects of Aqueous Extract of Berberis integerrima Root on Some Physiological Parameters in Streptozotocin-Induced Diabetic Rats . Iranian Journal of Pharmaceutical Research : IJPR. 2013;12(2):425-434. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813236/
- Ashraf H, Khaneshi F, Rafiee Raki F, Nejati V. Evaluation of aqueous extract of Berberis Integerrima root on the testis tissue and testosterone levels in stereptozotocine (stz) induced diabetic rats. Qom Univ Med Sci J. 2013;7:28–35.
- Rahimi-Madiseh M, Lorigoini Z, Zamani-gharaghoshi H, Rafieian-kopaei M. Berberis vulgaris: specifications and traditional uses. Iranian Journal of Basic Medical Sciences. 2017;20(5):569-587. doi:10.22038/IJBMS.2017.8690. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478785/
- Küpeli E, Koşar M, Yeşilada E, Hüsnü K, Başer C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci. 2002;72:645–657. https://www.ncbi.nlm.nih.gov/pubmed/12467905
- Laferriere JE, Weber CE, Kohlhepp EA. Use and nutritional composition of some traditional Mountain Pima plant foods. J Ethnobiol. 1991;11:93–114.
- Bsoul S, Terezhalmy G. Vitamin C in health and disease. J Contemp Dent Pract. 2004;5:1–13. https://www.ncbi.nlm.nih.gov/pubmed/15150630
- Fouladi RF. Aqueous extract of dried fruit of Berberis vulgaris L. in acne vulgaris, a clinical trial. J Diet Suppl. 2012;9:253–261. https://www.ncbi.nlm.nih.gov/pubmed/23038982
- SalehZadeh H, Iloun kashkooliR R, Najafi SS, Hosseini Asl MK, Hamedi A, Kalateh Sadati A. The effect of B-erberis vulgaris extract on blood pressure and Weight of the wPatients suffered from Non-alcoholic fatty liver disease. jgbfnm. 2013;10:21–27.
- Golzarand M, Ebrahimi-Mamaghani M, Arefhosseini S, Asgarzadeh AA. Effect of processed Berberis vulgaris in apple vinegar on blood pressure and inflammatory markers in type 2 diabetic patients. J Diabetes Metab Dis. 2008;7:3.
- Moazezi Z, Qujeq D. Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes. Jundishapur Journal of Natural Pharmaceutical Products. 2014;9(2):e13490. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036375/
- Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, Hajhassani G. The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients. Iranian Journal of Pharmaceutical Research : IJPR. 2012;11(2):643-652. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832145/
- Derosa G, Bonaventura A, Bianchi L, Romano D, D’Angelo A, Fogari E, et al. Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Exp Opin Biol Ther. 2013;13:1495–1506. https://www.ncbi.nlm.nih.gov/pubmed/23971720
- Bashir S, Gilani AH, Siddiqui AA, Pervez S, Khan SR, Sarfaraz NJ, et al. Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytother Res. 2010;24:1250–1255. https://www.ncbi.nlm.nih.gov/pubmed/20564494
- Kosalec I, Gregurek B, Kremer D, Zovko M, Sanković K, Karlović K. Croatian barberry (Berberis croatica Horvat):a new source of berberine—analysis and antimicrobial activity. World J Microbiol Biotechnol. 2009;25:145–150.
- Chueh WH, Lin JY. Berberine, an Isoquinoline Alkaloid in Herbal Plants, Protects Pancreatic Islets and Serum Lipids in Nonobese Diabetic Mice. J Agric Food Chem. 2014;59:8021–8027. https://www.ncbi.nlm.nih.gov/pubmed/21696141
- Landmark K. [Could intake of vitamins C and E inhibit development of Alzheimer dementia?] Tidsskr Nor Laegeforen. 2006;126:159–161. https://www.ncbi.nlm.nih.gov/pubmed/16415937
- Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y. CRiteria and recommendations for vitamin c intake. JAMA. 1999;281:1415–1423. https://www.ncbi.nlm.nih.gov/pubmed/10217058
- Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacology, biochemistry, and behavior. 2009;93(4):443-450. doi:10.1016/j.pbb.2009.06.006. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725435/
- Madiseh MR, Heidarian E, Rafieian-kopaei M. Biochemical components of Berberis lycium fruit and its effects on lipid profile in diabetic rats. J HerbMed Pharmacol. 2014;3:1.
- Devasagayam T, Tilak JC, Boloor KK, Sane Ketaki S, Ghaskadbi Saroj S, Lele RD (October 2004). “Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects”. Journal of Association of Physicians of India (JAPI). 52: 796.